Results 211 to 220 of about 57,535 (289)

Development of Mitochondria-Targeted PARP Inhibitors. [PDF]

Biomolecules
Dimitrijevs P, Makrecka-Kuka M, Arsenyan P.   +2 more
europepmc   +1 more source

Autoantikörper gegen Cardiolipin [PDF]

, 2017
W. Stöcker, W. Schlumberger
openaire   +2 more sources

Targeting High-Density Aromatic Peptides to Cardiolipin Optimizes the Mitochondrial Membrane Potential and Inhibits Oxidative Stress. [PDF]

FASEB Bioadv
Birk A, Arain S, Musumeci D, Garcia-Marin V, MacNeil MA.   +4 more
europepmc   +1 more source

GV1001, an hTERT-Derived Peptide, Prevents Cisplatin-Induced Nephrotoxicity by Preserving Mitochondrial Function. [PDF]

Cells
Chen W, Beheshtian C, Kim S, Kim R, Kim S, Park NH.   +5 more
europepmc   +1 more source

Deficiency of Cardiolipin Synthase Causes Abnormal Mitochondrial Function and Morphology in Germ Cells of Caenorhabditis elegans

, 2011
Taro Sakamoto, Takao Inoué, Yukae Otomo, Nagaharu Yokomori, M Ohno, Hiroyuki Arai, Yasuhito Nakagawa   +6 more
openalex   +1 more source

Antibodies to Periodontal Bacteria Are Associated with Systemic Lupus Erythematosus and Autoantibody Positivity. [PDF]

Int J Mol Sci
Massarenti L, Leffers HCB, Brodersen T, Hansen PR, Damgaard C, Pedersen OB, Jacobsen S, Nielsen CH.   +7 more
europepmc   +1 more source

Extended cardiolipin anchorage to cytochrome c: a model for protein–mitochondrial membrane binding

, 2010
Federica Sinibaldi, Barry D. Howes, Maria Cristina Piro, Fabio Polticelli, Cecilia Bombelli, Tommaso Ferri, Massimo Coletta, Giulietta Smulevich, Roberto Santucci   +8 more
openalex   +2 more sources

Letter to the Editor: CRISPR-based gene editing for cardiac protection in Barth syndrome. [PDF]

Ann Med Surg (Lond)
Abedin ZU, Waggan AI, Khan E, Suleman MU, Tabassum SN.   +4 more
europepmc   +1 more source

Total cardiolipin levels in gastric and colon cancer: evaluating the prognostic potential [PDF]

Pāvels Dimitrijevs, Ilona Freiliba, Andrejs Pčolkins, Mārcis Leja, Pavel Arsenyan   +4 more
openalex   +1 more source

Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models. [PDF]

Nat Commun
Dong C, Finigan A, Figg N, Jenkins B, Koulman A, Chowdhury SR, Tricolici AM, Lambert J, Oc S, Jørgensen HF, Prudent J, Murphy MP, Bennett M, Yu E.   +13 more
europepmc   +1 more source